News

Press Releases

Viscira Delivers Key Presentation to Pharmaceutical Marketing Professionals at Leading Digital Industry Conference

Viscira™, a leading provider of interactive and new-media solutions for the life sciences industry, delivered a highly relevant presentation entitled, “Maximizing Return on Interactive” at the Digital Pharma West (DPW) conference last week in San Francisco.

Dave Gulezian, President and CEO of Viscira, spoke about the top do’s and don’ts in interactive healthcare marketing to an interested audience of marketing professionals from top biotech, pharma, and medical device companies. The presentation included specific strategic and tactical recommendations for product marketers who are now beginning the 2011 brand planning process. It also utilized the company’s Flash-based, enhanced slide-deck technology, which continues to grow in adoption across the industry.

“It was exciting to present at an industry event that is rapidly becoming the leading forum for the intersection of technology, innovation, and social media in healthcare marketing,” explains Gulezian. “It was also great to hear that many attendees thought our presentation was very beneficial and timely given their priorities right now”.

Viscira was also a sponsor of the conference, which explored how the interaction among patients, healthcare providers, and pharmaceutical marketers is improved through the use of new technologies and innovations such as social media. The DPW event also attracted presenters from other industry leaders such as Eli Lilly, Amgen, Genentech, and AstraZeneca.

Interested parties can download a copy of the presentation in either PC or MAC format using the web links below:

Viscira Maximizing ROI Presentation - PC Format

https://viscira.sharefile.com/d/sa1fc0b31ebf45429

*Please click on the DPW_PC.exe file after downloading.

Viscira Maximizing ROI Presentation - MAC Format

https://viscira.sharefile.com/d/sd6feca5c8154a57a

*Please click on the DPW_MAC file after downloading.

Press Contact:
Noël Ashekian
Marketing Communications Manager - Viscira
Phone: (617) 429-0834
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Click Here to read this article on PRWeb

Viscira Announces Version 2.0 of its Online Interactive Slide Kit Builder Application

Viscira™, a leading provider of interactive and new-media solutions for the life sciences industry, today announced the release of Version 2.0 of its Interactive Slide Kit Builder application for pharmaceutical, biotech, and medical device customers. Viscira’s web-based software platform provides users with the ability to create and save custom presentations using approved slides through an intuitive graphical user interface.

Some of the many robust features included with the upgraded application are as follows:

  • The ability to quickly create and save custom presentations in multiple delivery formats including PowerPoint, PDF, Flash, and other enhanced, new-media formats.
  • Embedded programming logic which can require users to use certain slides in combination and include specific mandatory slides.
  • Customizable access levels which allow specific users to view only certain slide groupings and perform only designated functions.
  • The ability to publish any slide updates to all saved presentation slide decks in real time.
  • A full companion administrative tool enabling authorized users to add/delete users, upload new slide decks, send notifications, and generate reports.

The Viscira Interactive Slide Kit Builder is a secure, web-based platform with a flexible technology architecture that has been designed to maximize functionality and ease-of-use for users. It can be seamlessly integrated into an existing client website or speaker extranet, and can be tailored to comply with specific customer workflow and regulatory compliance requirements. It can also be delivered as a stand-alone, offline application.

“Our new Interactive Slide Kit Builder product incorporates next-generation technology and many innovative features that provide significant benefit to life science companies and their product speakers beyond current industry offerings”, explains Dave Gulezian, President and CEO of Viscira. “It also offers our customers expanded presentation flexibility, while maintaining their adherence to pharma regulatory guidelines and industry best practices.”

To schedule a review and demonstration of the Viscira Interactive Slide Kit Builder application, please contact the company at 415-848-8010 or send an email to This email address is being protected from spambots. You need JavaScript enabled to view it..

This product is just one of many innovative interactive and new-media solutions the company offers, which range from 3D mechanism of action animations to enhanced KOL video presentation modules to interactive sales aids. Viscira’s strategic approach combined with its delivery of cutting-edge products has resulted in an impressive roster of clients for the company including Amgen, Johnson & Johnson, Genentech, Pfizer and Novartis.

Press Contact:
Noël Ashekian
Marketing Communications Manager - Viscira
Phone: (617) 429-0834
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Click Here to read this article on PRWeb

Viscira™ Earns Industry Praise for Next-Generation 3D Animation Production

3D animation has progressed significantly - from the hand-drawn techniques used in the 1940 production of Pinocchio to the groundbreaking technologies used to create the 2009 science fiction epic film, Avatar. While many are familiar with the use of animation by the motion picture industry, most are not as aware of its potential within the medical environment.

Viscira, a leading provider of interactive and new-media solutions for the life sciences industry, is capitalizing on this opportunity by offering deep and broad experience in 3D disease state and mechanism of action (MOA) animation development. Viscira is raising the bar for animation productions having recently received industry praise for an animation video it featured at the 2009 American Society of Clinical Oncology (ASCO) Meeting.

Brad Peebler, CEO of Luxology, the software developer for the featured animation, commented on Viscira’s delivery at ASCO. “We are impressed with the quality and sophistication of animation that Viscira is able to deliver. It’s great to see some of the unique effects that are typically reserved for feature-film production incorporated into a medical video.”

While Viscira’s cinematic animations engage and entertain viewers, they also educate through a medically-sophisticated, storytelling approach that strives for scientific accuracy even at a cellular or molecular level. When appropriate, Viscira’s animations can provide viewers with a photo-realistic visual experience that might resemble the perspective of looking through a microscope.

According to Hagop (Kane) Kaneboughazian, Viscira’s Director of Animation, success depends on blending creative design with science. “We start with primary research on a disease state and product, key message definition and script development. It’s critical to understand the science first to make sure that the visual components are not only aesthetically impactful, but also technically correct.”

Viscira produces stunning 3D animations that can be customized for healthcare professionals, as well as patients. The company’s animation team brings together multiple functions including medical writers, storyboard artists and motion graphics developers. Viscira’s technical animation development suite integrates some of the same software programs and tools being utilized by companies such as Pixar and Lucasfilm, in addition to in-house applications.

Viscira’s next-generation 3D animations are just one of many interactive and new-media solutions the company offers, which range from web-based interactive slide kit builder platforms to enhanced video presentation modules to virtual-reality tradeshow programs. Viscira’s strategic approach combined with its delivery of cutting-edge products has resulted in an impressive roster of clients for the company including Amgen, Johnson & Johnson, Genentech, Pfizer and Novartis.

Press Contact:
Noël Ashekian
Marketing Communications Manager - Viscira
Phone: (617) 429-0834
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Click Here to read this article on PRWeb

Viscira Expands Interactive Solutions to Reduce Marketing Expenses for Pharmaceutical Companies in Challenging Economic Times

The current poor economic conditions have driven many companies to take cost cutting measures to maintain profitability. Marketing is certainly one area of focus as companies look for more affordable and efficient ways to reach their customers.

During these turbulent economic times, pharmaceutical companies are also looking to gain efficiencies by seeking lower cost and more streamlined distribution channels to reach health care professionals and patients, especially as the sales force numbers continue to shrink. According to a March 2009 report published by consulting firm ZS Associates, the number of pharmaceutical reps decreased from 102,000 in 2007 to 92,000 in the first quarter of 2009. This number is expected to dip to as low as 75,000 by 2012.*

Viscira (http://www.viscira.com), a San Francisco based interactive and new-media company delivering innovative technology solutions to the life sciences industry, is responding to these challenges by leveraging electronic channels such as the web, email and mobile devices in new and compelling ways to enable life science clients to directly reach their target audiences.

Viscira provides a variety of innovative and differentiated interactive solutions ranging from next-generation 3D product animations and interactive medical case studies to web-based speaker training platforms and electronic journal reprints to deliver dynamic content to an industry that understands the importance of innovation. The company continues to expand its product offerings to respond to the growing demands of customers.

“Many of our technology solutions can be delivered directly to end users and can also be cost-effectively repurposed for multiple distribution channels to help maximize client investment.” explains Dave Gulezian, President and CEO of Viscira. “Moreover, we offer a number of unique products that can help make the pharma sales force more effective even if their overall numbers might be smaller.”

Further facilitating this shift is the growing acceptance and adoption of new technology and electronic communication by patients and healthcare professionals. In fact, the number of physicians who use the Internet and other technology to access pharmaceutical, biotech, and medical device information has grown to almost 90% of the total U.S. physician population.**

“The Internet and other new media channels are becoming increasingly important ways for myself and my colleagues to stay current on new developments in patient care,” says Dr. Anthony Padula, a leading rheumatologist practicing in the San Francisco Bay area. “However, the quality of the educational programs delivered through these channels must be very high if they are to be effective.”

Beyond providing innovative interactive products, Viscira takes a strategic approach when working with its clients by investing in fully understanding their marketing goals and objectives. This methodology allows the company to leverage its technology expertise, marketing savvy and scientific knowledge to obtain outstanding results.

Viscira’s strategic approach combined with its delivery of cutting-edge products has resulted in an impressive roster of clients for the company including Amgen, Johnson & Johnson, Genentech, Pfizer and Novartis. The company also boasts a medical advisory board comprised of leading healthcare practitioners from some of the country’s leading medical institutions.

*Drivers of Change to Pharmaceutical Commercial Models, ZS Associates, March 2009.

**Plugging into Physicians: Digital Marketing & Sales Strategies for Healthcare Companies, Manhattan Research, 2008.

Press Contact:
Noël Ashekian
Marketing Communications Manager - Viscira
Phone: (617) 429-0834
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Click Here to read this article on PRWeb

News by Year Press Releases - News page